{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Anti-cancer effect", "Neuroblastoma", "No-ozone cold plasma", "Plasma activated medium"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "38245726", "DateCompleted": {"Year": "2024", "Month": "01", "Day": "22"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "02"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "20"}], "ELocationID": ["46", "10.1186/s12906-023-04313-0"], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jan", "Day": "20"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "No-ozone cold plasma induces apoptosis in human neuroblastoma cell line via increased intracellular reactive oxygen species (ROS).", "Pagination": {"StartPage": "46", "MedlinePgn": "46"}, "Abstract": {"AbstractText": ["This study aimed to evaluate the effect of argon-based No-ozone Cold Plasma (NCP) on neuroblastoma cancer cell apoptosis.", "Experiments were performed with SK-N-SH and HS 68. Cell cultures were treated with NCP for 1, 3, and 5\u00a0min. NCP was applied using three different strategies: direct NCP application to cell cultures, to only media, and to only cells. Evaluation of cell viability and the level of the reactive oxygen species (ROS) was performed. N-acetyl-L-cysteine (NAC) was also used to antagonize intracellular ROS. Cleaved caspase 3, PARP, aquaporin (AQP) 3 and 8 were detected.", "NCP induced a gradual decrease in the SK-N-SH cell viability. In contrast, the viability of HS 68 cells did not change. SK-N-SH cells viability was reduced the most when the only media-NCP application strategy was employed. Intracellular ROS levels were significantly increased with time. Cleaved caspase 3 and PARP were increased at 6\u00a0h after NCP application. SK-N-SH cells remained viable with NAC after NCP application. AQP 3 and 8 were over-expressed in SK-N-SH cells.", "These findings demonstrate the anti-cancer effect of NCP on neuroblastoma cells. NCP enhanced the selective apoptosis of neuroblastoma cells due to the increased intracellular ROS."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oral and Maxillofacial Surgery, Dental and Life Science Institute, Dental School, Pusan National University, Busan, South Korea."}], "LastName": "Lee", "ForeName": "Jung-Han", "Initials": "JH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oral and Maxillofacial Surgery, Dental and Life Science Institute, Dental School, Pusan National University, Busan, South Korea."}], "LastName": "Jaiswal", "ForeName": "M Shriya", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oral and Maxillofacial Surgery, Dental and Life Science Institute, Dental School, Pusan National University, Busan, South Korea."}], "LastName": "Jang", "ForeName": "Yoon-Seo", "Initials": "YS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Research and Development, FEAGLE Corporations, 70-6, Jeungsan-ro, Mulgeum-eup, Yangsan-si, 50614, Gyeongsangnam-do, South Korea."}], "LastName": "Choi", "ForeName": "Jeong-Hae", "Initials": "JH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Research and Development, FEAGLE Corporations, 70-6, Jeungsan-ro, Mulgeum-eup, Yangsan-si, 50614, Gyeongsangnam-do, South Korea."}, {"Identifier": [], "Affiliation": "Department of Oral Anatomy and Cell Biology, School of Dentistry, Pusan National University, Busan, South Korea."}], "LastName": "Kim", "ForeName": "Gyoo-Cheon", "Initials": "GC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, School of Korean Medicine, Yangsan Campus of Pusan National University, Beomeo-ri, Mulgeum-eup, Yangsan-si, 50612, Gyeongsangnam-do, South Korea. jwhong@pusan.ac.kr."}], "LastName": "Hong", "ForeName": "Jin-Woo", "Initials": "JW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oral and Maxillofacial Surgery, Dental and Life Science Institute, Dental School, Pusan National University, Busan, South Korea. dshwang@pusan.ac.kr."}, {"Identifier": [], "Affiliation": "Dental Research Institute, Pusan National University Dental Hospital, Yangsan, South Korea. dshwang@pusan.ac.kr."}, {"Identifier": [], "Affiliation": "Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University, Beomeo-ri, Mulgeum-eup, Yangsan-si, 50612, Gyeongsangnam-do, South Korea. dshwang@pusan.ac.kr."}], "LastName": "Hwang", "ForeName": "Dae-Seok", "Initials": "DS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}, {"RegistryNumber": "0", "NameOfSubstance": "Plasma Gases"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "0", "NameOfSubstance": "Poly(ADP-ribose) Polymerase Inhibitors"}, {"RegistryNumber": "WYQ7N0BPYC", "NameOfSubstance": "Acetylcysteine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspase 3"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plasma Gases"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Poly(ADP-ribose) Polymerase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neuroblastoma"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Acetylcysteine"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3(3):203\u2013216. doi: 10.1038/nrc1014.", "ArticleIdList": ["10.1038/nrc1014", "12612655"]}, {"Citation": "Maris JM, et al. Neuroblastoma. Lancet. 2007;369(9579):2106\u201320. doi: 10.1016/S0140-6736(07)60983-0.", "ArticleIdList": ["10.1016/S0140-6736(07)60983-0", "17586306"]}, {"Citation": "Perez CA, et al. Biologic variables in the outcome of stages I and II neuroblastoma treated with Surgery as primary therapy: a children\u2019s cancer group study. J Clin Oncol. 2000;18(1):18\u201326. doi: 10.1200/JCO.2000.18.1.18.", "ArticleIdList": ["10.1200/JCO.2000.18.1.18", "10623689"]}, {"Citation": "Matthay KK, et al. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol. 1989;7(2):236\u2013244. doi: 10.1200/JCO.1989.7.2.236.", "ArticleIdList": ["10.1200/JCO.1989.7.2.236", "2915240"]}, {"Citation": "Kushner BH, et al. International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review. J Clin Oncol. 1996;14(7):2174\u201380. doi: 10.1200/JCO.1996.14.7.2174.", "ArticleIdList": ["10.1200/JCO.1996.14.7.2174", "8683252"]}, {"Citation": "Escobar MA, et al. Long-term outcomes in patients with stage IV neuroblastoma. J Pediatr Surg. 2006;41(2):377\u2013381. doi: 10.1016/j.jpedsurg.2005.11.032.", "ArticleIdList": ["10.1016/j.jpedsurg.2005.11.032", "16481255"]}, {"Citation": "Pinto NR, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015;33(27):3008\u20133017. doi: 10.1200/JCO.2014.59.4648.", "ArticleIdList": ["10.1200/JCO.2014.59.4648", "PMC4567703", "26304901"]}, {"Citation": "Smith V, Foster J. High-risk neuroblastoma treatment review. Children (Basel) 2018;5(9):114.", "ArticleIdList": ["PMC6162495", "30154341"]}, {"Citation": "Castleberry RP, Kun LE, Shuster JJ, Altshuler G, Smith IE, Nitschke R, Wharam M, McWilliams N, Joshi V, Hayes FA. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol. 1991;9(5):789\u2013795. doi: 10.1200/JCO.1991.9.5.789.", "ArticleIdList": ["10.1200/JCO.1991.9.5.789", "2016621"]}, {"Citation": "Miles SA, Sandler AD. CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma. Adv Drug Deliv Rev. 2009;61(3):275\u2013282. doi: 10.1016/j.addr.2008.12.011.", "ArticleIdList": ["10.1016/j.addr.2008.12.011", "19186194"]}, {"Citation": "Matthay KK, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children\u2019s Cancer Group. N Engl J Med. 1999;341(16):1165\u20131173. doi: 10.1056/NEJM199910143411601.", "ArticleIdList": ["10.1056/NEJM199910143411601", "10519894"]}, {"Citation": "Frappaz D, et al. The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis. Br J Cancer. 2002;87(11):1197\u20131203. doi: 10.1038/sj.bjc.6600627.", "ArticleIdList": ["10.1038/sj.bjc.6600627", "PMC2408899", "12439705"]}, {"Citation": "Weinstein JL, Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. Oncologist. 2003;8(3):278\u201392. doi: 10.1634/theoncologist.8-3-278.", "ArticleIdList": ["10.1634/theoncologist.8-3-278", "12773750"]}, {"Citation": "Kieft IE, et al. Electric discharge plasmas influence attachment of cultured CHO K1 cells. Bioelectromagnetics. 2004;25(5):362\u2013368. doi: 10.1002/bem.20005.", "ArticleIdList": ["10.1002/bem.20005", "15197760"]}, {"Citation": "Morozov AI. Introduction to Plasma Dynamics (1st ed.). CRC Press;\u00a0 2013. 10.1201/b13929."}, {"Citation": "Stoffels E, Flikweert AA, Stoffels WW, Kroesen GM. Plasma needle: a non-destructive atmospheric plasma source for fine surface treatment of (bio)materials. Plasma Sources Sci Technol. 2002;2002(11):383\u2013388. doi: 10.1088/0963-0252/11/4/304.", "ArticleIdList": ["10.1088/0963-0252/11/4/304"]}, {"Citation": "Laroussi M. Plasma medicine: a brief introduction. Plasma. 2018;1(1):47\u201360. doi: 10.3390/plasma1010005.", "ArticleIdList": ["10.3390/plasma1010005"]}, {"Citation": "Fridman G, et al. Comparison of direct and indirect effects of non-thermal atmospheric-pressure plasma on bacteria. Plasma Processes Polym. 2007;4(4):370\u2013375. doi: 10.1002/ppap.200600217.", "ArticleIdList": ["10.1002/ppap.200600217"]}, {"Citation": "Kl\u00e4mpfl TG, et al. Cold atmospheric air plasma sterilization against spores and other microorganisms of clinical interest. Appl Environ Microbiol. 2012;78(15):5077\u20135082. doi: 10.1128/AEM.00583-12.", "ArticleIdList": ["10.1128/AEM.00583-12", "PMC3416436", "22582068"]}, {"Citation": "Kubinova S, et al. Non-thermal air plasma promotes the healing of acute skin wounds in rats. Sci Rep. 2017;7(1):45183. doi: 10.1038/srep45183.", "ArticleIdList": ["10.1038/srep45183", "PMC5364525", "28338059"]}, {"Citation": "Choi J-H, et al. Low-temperature atmospheric plasma increases the expression of anti-aging genes of skin cells without causing cellular damages. Arch Dermatol Res. 2013;305(2):133\u2013140. doi: 10.1007/s00403-012-1259-8.", "ArticleIdList": ["10.1007/s00403-012-1259-8", "22773133"]}, {"Citation": "Georgescu N, Lupu AR. Tumoral and normal cells treatment with high-voltage pulsed cold atmospheric plasma jets. IEEE Trans Plasma Sci. 2010;38(8):1949\u20131955. doi: 10.1109/TPS.2010.2041075.", "ArticleIdList": ["10.1109/TPS.2010.2041075"]}, {"Citation": "Zirnheld JL, et al. Nonthermal plasma needle: development and targeting of melanoma cells. IEEE Trans Plasma Sci. 2010;38(4):948\u2013952. doi: 10.1109/TPS.2010.2041470.", "ArticleIdList": ["10.1109/TPS.2010.2041470"]}, {"Citation": "Kim JY, et al. A flexible cold microplasma jet using biocompatible dielectric tubes for cancer therapy. Appl Phys Lett. 2010;96(20):203701. doi: 10.1063/1.3431392.", "ArticleIdList": ["10.1063/1.3431392"]}, {"Citation": "Keidar M, et al. Cold atmospheric plasma in cancer therapy. Phys Plasmas. 2013;20(5):057101. doi: 10.1063/1.4801516.", "ArticleIdList": ["10.1063/1.4801516"]}, {"Citation": "Volotskova O, et al. Targeting the cancer cell cycle by cold atmospheric plasma. Sci Rep. 2012;2(1):636. doi: 10.1038/srep00636.", "ArticleIdList": ["10.1038/srep00636", "PMC3434394", "22957140"]}, {"Citation": "Chen Q, et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci. 2007;104(21):8749\u20138754. doi: 10.1073/pnas.0702854104.", "ArticleIdList": ["10.1073/pnas.0702854104", "PMC1885574", "17502596"]}, {"Citation": "Du J, et al. Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res. 2010;16(2):509\u2013520. doi: 10.1158/1078-0432.CCR-09-1713.", "ArticleIdList": ["10.1158/1078-0432.CCR-09-1713", "PMC2807999", "20068072"]}, {"Citation": "Kang SW. Role of reactive oxygen species in cell death pathways. Hanyang Med Reviews. 2013;33(2):77. doi: 10.7599/hmr.2013.33.2.77.", "ArticleIdList": ["10.7599/hmr.2013.33.2.77"]}, {"Citation": "L\u00f3pez-L\u00e1zaro M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett. 2007;252(1):1\u20138. doi: 10.1016/j.canlet.2006.10.029.", "ArticleIdList": ["10.1016/j.canlet.2006.10.029", "17150302"]}, {"Citation": "Keidar M. Plasma for cancer treatment. Plasma Sources Sci Technol. 2015;24(3):033001. doi: 10.1088/0963-0252/24/3/033001.", "ArticleIdList": ["10.1088/0963-0252/24/3/033001"]}, {"Citation": "Yan D, et al. Toward understanding the selective anticancer capacity of cold atmospheric plasma\u2014a model based on aquaporins (review) Biointerphases. 2015;10(4):040801. doi: 10.1116/1.4938020.", "ArticleIdList": ["10.1116/1.4938020", "26700469"]}, {"Citation": "Saito K, et al. Tumor-selective mitochondrial network collapse induced by atmospheric gas plasma-activated medium. Oncotarget. 2016;7(15):19910\u201319927. doi: 10.18632/oncotarget.7889.", "ArticleIdList": ["10.18632/oncotarget.7889", "PMC4991427", "26942565"]}, {"Citation": "Song K, Li G, Ma Y. A review on the selective apoptotic effect of nonthermal atmospheric-pressure plasma on cancer cells. Plasma Med. 2014;4(1\u20134):193\u2013209. doi: 10.1615/PlasmaMed.2015012629.", "ArticleIdList": ["10.1615/PlasmaMed.2015012629"]}, {"Citation": "Lee S-T, et al. Non-thermal plasma application enhances the recovery of transected sciatic nerves in rats. Exp Biol Med. 2021;246(11):1287\u20131296. doi: 10.1177/1535370221996655.", "ArticleIdList": ["10.1177/1535370221996655", "PMC8371309", "33653158"]}, {"Citation": "Choi JH, et al. Skin renewal activity of non-thermal plasma through the activation of \u03b2-catenin in keratinocytes. Sci Rep. 2017;7(1):6146. doi: 10.1038/s41598-017-06661-7.", "ArticleIdList": ["10.1038/s41598-017-06661-7", "PMC5522407", "28733577"]}, {"Citation": "Park N-S, et al. No-ozone cold plasma can kill oral pathogenic microbes in H2O2-dependent and independent manner. Sci Rep. 2022;12(1):7597. doi: 10.1038/s41598-022-11665-z.", "ArticleIdList": ["10.1038/s41598-022-11665-z", "PMC9085805", "35534525"]}, {"Citation": "Lee HJ, et al. Degradation of adhesion molecules of G361 melanoma cells by a non-thermal atmospheric pressure microplasma. New J Phys. 2009;11:115026. doi: 10.1088/1367-2630/11/11/115026.", "ArticleIdList": ["10.1088/1367-2630/11/11/115026"]}, {"Citation": "Park GY, et al. Atmospheric-pressure plasma sources for biomedical applications. Plasma Sources Sci Technol. 2012;21(4):043001. doi: 10.1088/0963-0252/21/4/043001.", "ArticleIdList": ["10.1088/0963-0252/21/4/043001"]}, {"Citation": "Choi J-H, et al. Inhibition of inflammatory reactions in 2,4-Dinitrochlorobenzene induced Nc/Nga atopic dermatitis mice by non-thermal plasma. Sci Rep. 2016;6(1):27376. doi: 10.1038/srep27376.", "ArticleIdList": ["10.1038/srep27376", "PMC4897616", "27271011"]}, {"Citation": "Yan D, Sherman JH, Keidar M. Cold atmospheric plasma, a novel promising anti-cancer treatment modality. Oncotarget. 2017;8(9):15977\u201315995. doi: 10.18632/oncotarget.13304.", "ArticleIdList": ["10.18632/oncotarget.13304", "PMC5362540", "27845910"]}, {"Citation": "Chernets N, et al. Reaction chemistry generated by nanosecond pulsed dielectric barrier discharge treatment is responsible for the tumor eradication in the B16 melanoma mouse model. Plasma Processes Polym. 2015;12(12):1400\u20131409. doi: 10.1002/ppap.201500140.", "ArticleIdList": ["10.1002/ppap.201500140", "PMC5667549", "29104522"]}, {"Citation": "Yan D, et al. The specific vulnerabilities of cancer cells to the cold atmospheric plasma-stimulated solutions. Sci Rep. 2017;7(1):4479. doi: 10.1038/s41598-017-04770-x.", "ArticleIdList": ["10.1038/s41598-017-04770-x", "PMC5493667", "28667316"]}, {"Citation": "Adachi T, et al. Plasma-activated medium induces A549 cell injury via a spiral apoptotic cascade involving the mitochondrial-nuclear network. Free Radic Biol Med. 2015;79:28\u201344. doi: 10.1016/j.freeradbiomed.2014.11.014.", "ArticleIdList": ["10.1016/j.freeradbiomed.2014.11.014", "25433364"]}, {"Citation": "Yan D, et al. Principles of using cold atmospheric plasma stimulated media for cancer treatment. Sci Rep. 2015;5(1):18339. doi: 10.1038/srep18339.", "ArticleIdList": ["10.1038/srep18339", "PMC4683589", "26677750"]}, {"Citation": "Verkman AS. Aquaporins in clinical medicine. Annu Rev Med. 2012;63:303\u2013316. doi: 10.1146/annurev-med-043010-193843.", "ArticleIdList": ["10.1146/annurev-med-043010-193843", "PMC3319404", "22248325"]}, {"Citation": "Papadopoulos MC, Saadoun S. Key roles of aquaporins in tumor biology. Biochim Biophys Acta. 2015;1848(10 Pt B):2576\u20132583. doi: 10.1016/j.bbamem.2014.09.001.", "ArticleIdList": ["10.1016/j.bbamem.2014.09.001", "25204262"]}, {"Citation": "Bienert GP, Chaumont F. Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide. Biochim Biophys Acta. 2014;1840(5):1596\u20131604. doi: 10.1016/j.bbagen.2013.09.017.", "ArticleIdList": ["10.1016/j.bbagen.2013.09.017", "24060746"]}, {"Citation": "Miller EW, Dickinson BC, Chang CJ. Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc Natl Acad Sci. 2010;107(36):15681\u201315686. doi: 10.1073/pnas.1005776107.", "ArticleIdList": ["10.1073/pnas.1005776107", "PMC2936599", "20724658"]}, {"Citation": "Almasalmeh A, et al. Structural determinants of the hydrogen peroxide permeability of aquaporins. FEBS J. 2014;281(3):647\u2013656. doi: 10.1111/febs.12653.", "ArticleIdList": ["10.1111/febs.12653", "24286224"]}, {"Citation": "Kawasaki T, et al. Effects of irradiation distance on supply of reactive oxygen species to the bottom of a Petri dish filled with liquid by an atmospheric O2/He plasma jet. J Appl Phys. 2016;119(17):173301. doi: 10.1063/1.4948430.", "ArticleIdList": ["10.1063/1.4948430"]}, {"Citation": "Watanabe S, et al. Aquaporin-9 facilitates membrane transport of hydrogen peroxide in mammalian cells. Biochem Biophys Res Commun. 2016;471(1):191\u2013197. doi: 10.1016/j.bbrc.2016.01.153.", "ArticleIdList": ["10.1016/j.bbrc.2016.01.153", "26837049"]}, {"Citation": "Gal\u00e1n-Cobo A, Ram\u00edrez-Lorca R, Echevarr\u00eda M. Role of aquaporins in cell proliferation: what else beyond water permeability? Channels. 2016;10(3):185\u2013201. doi: 10.1080/19336950.2016.1139250.", "ArticleIdList": ["10.1080/19336950.2016.1139250", "PMC4954585", "26752515"]}, {"Citation": "Yan D, et al. The role of aquaporins in the anti-glioblastoma capacity of the cold plasma-stimulated medium. J Phys D. 2017;50(5):055401. doi: 10.1088/1361-6463/aa53d6.", "ArticleIdList": ["10.1088/1361-6463/aa53d6"]}, {"Citation": "Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol. 2007;8(5):405\u2013413. doi: 10.1038/nrm2153.", "ArticleIdList": ["10.1038/nrm2153", "17377525"]}, {"Citation": "Yan D, et al. Multi-modal biological destruction by cold atmospheric plasma: capability and mechanism. Biomedicines. 2021;9(9):1259. doi: 10.3390/biomedicines9091259.", "ArticleIdList": ["10.3390/biomedicines9091259", "PMC8465976", "34572443"]}, {"Citation": "Kim JY, et al. Apoptosis of lung carcinoma cells induced by a flexible optical fiber-based cold microplasma. Biosens Bioelectron. 2011;28(1):333\u2013338. doi: 10.1016/j.bios.2011.07.039.", "ArticleIdList": ["10.1016/j.bios.2011.07.039", "21820891"]}, {"Citation": "Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10(1):45\u201365. doi: 10.1038/sj.cdd.4401189.", "ArticleIdList": ["10.1038/sj.cdd.4401189", "12655295"]}, {"Citation": "Gobeil S, Boucher CC, Nadeau D, Poirier GG. Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ. 2001;8(6):588\u2013594. doi: 10.1038/sj.cdd.4400851.", "ArticleIdList": ["10.1038/sj.cdd.4400851", "11536009"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "29"}, {"Year": "2023", "Month": "12", "Day": "12"}, {"Year": "2024", "Month": "1", "Day": "22", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "21", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "20", "Hour": "23", "Minute": "27"}, {"Year": "2024", "Month": "1", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["38245726", "PMC10799363", "10.1186/s12906-023-04313-0", "10.1186/s12906-023-04313-0"]}}], "PubmedBookArticle": []}